Accelerating a Schizophrenia Trial While Ensuring Quality Collaboration Success Stories

Accelerating a Schizophrenia Trial While Ensuring Quality

In CNS drug development, timelines aren't just project management benchmarks. They're tied to corporate milestones,…

cogres1March 16, 2026

2026 Trends Shaping CNS Clinical Research Expert Insights

2026 Trends Shaping CNS Clinical Research

Clarity for Sponsors Building the Next Generation of CNS Therapies CNS clinical development continues to…

cogres1February 12, 2026

What Psychedelic Clinical Trials Need Now: Key Takeaways from the Bold Conversation Expert Insights

What Psychedelic Clinical Trials Need Now: Key Takeaways from the Bold Conversation

Psychedelic drug development is accelerating, yet many of the core structures that support rigorous, interpretable…

cogres1December 8, 2025

Pledge to Be Bold: A Collective Movement for Progress in CNS Clinical Research Inside CRC

Pledge to Be Bold: A Collective Movement for Progress in CNS Clinical Research

Bold research is more than a phrase at CRC. It reflects the mindset required to…

cogres1November 11, 2025

Purpose in Practice: World Mental Health Day 2025 Inside CRC

Purpose in Practice: World Mental Health Day 2025

Each year, World Mental Health Day calls attention to the need for greater understanding, access,…

cogres1October 31, 2025

Alzheimer’s Stories at the Heart of Our Why Inside CRC

Alzheimer’s Stories at the Heart of Our Why

September is World Alzheimer’s Month, an international campaign to raise dementia awareness and challenge stigma.…

cogres1October 31, 2025

Speed Kills: Is Your Neuropsychiatric Trial at Risk? Expert Insights

Speed Kills: Is Your Neuropsychiatric Trial at Risk?

Why do so many neuropsychiatric trials fail? It is a question that sponsors, investigators, and…

cogres1September 10, 2025

CRC Appoints Jason Casarella, MBA as Chief Commercial Officer Breaking News

CRC Appoints Jason Casarella, MBA as Chief Commercial Officer

ST. PETERSBURG, Fla., Sept. 2, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a leading full-service…

cogres1September 2, 2025

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories Expert Insights

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories

Psychedelic medicine has re-emerged as one of the most exciting frontiers in psychiatric and psychological…

cogres1August 20, 2025

CRC Becomes Accredited Medidata Rave® EDC Partner Breaking News

CRC Becomes Accredited Medidata Rave® EDC Partner

ST. PETERSBURG, Fla., Aug. 12, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a full-service CRO…

cogres1August 12, 2025

Mastering Agitation Endpoints with Assessment Expertise Collaboration Success Stories

Mastering Agitation Endpoints with Assessment Expertise

Consistent, high-quality assessments are essential in agitation trials. In this focused case study, see how…

cogres1July 30, 2025

Seamless Execution Across Early-Phase Alzheimer’s Trials Collaboration Success Stories

Seamless Execution Across Early-Phase Alzheimer’s Trials

In the face of pandemic-era recruitment barriers and aggressive timelines, CRC partnered with a sponsor…

cogres1July 15, 2025